EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Evaluation of point‐of‐care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study

Dvora Joseph Davey iD, Lauren Fynn iD, Elzette Rousseau iD, Pippa Macdonald, Bryan Leonard, Keitumese Lebelo, Ande Kolisa, Francesca Little, Linda-Gail Bekker iD

Journal of the International AIDS Society · 2025

DOI: 10.1002/jia2.26488 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Dvora Joseph Davey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Geffen School of Medicine, University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, Point-of-Care Testing, HIV Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Bill and Melinda Gates Foundation to Desmond Tutu HIV Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pre‐exposure prophylaxis (PrEP) services are linked to increased sexually transmitted infection (STI) diagnoses, which may facilitate PrEP uptake. We hypothesized that point‐of‐care (POC) STI testing and treatment would improve PrEP initiation and persistence.

Methods

Between September 2023 and November 2024, we conducted a single‐centre, open‐label, unblinded, randomized controlled trial among adolescent girls and young women (15−29 years old) or male partners (any age). Participants were randomized 1:1 to standard syndromic STI management (SOC) or POC testing for C. trachomatis , N. gonorrhoeae , syphilis and T. vaginalis (women only). All participants received standard HIV prevention counselling, including the offer of oral PrEP. The primary outcome was effect of POC STI testing versus syndromic management on PrEP initiation; secondary outcomes included persistence at 1 and 4 months (PrEP prescription), verified in the secondary analysis of tenofovir diphosphate (TFV‐DP) in dried blood spots (DBS) in a random subset. TFV‐DP in DBS was analysed in a subset. Analysis was intention‐to‐treat, adjusted for age and sex.

Results

We enrolled and randomized 900 participants (452 in intervention; 448 in SOC). The mean age was 20.4 years (SD = 4.2); 48% were female. In the intervention arm, 435 received POC STI testing (96%); 25% (110 of 435 tested) were diagnosed with =>1 STIs; 84% were treated. In SOC, 7% of participants reported symptoms of STIs (31); 88% were treated (27). Overall, 64% of participants in SOC versus 62% in intervention‐initiated PrEP (RR = 0.98, 95% CI = 0.88ng women and partners1.08). In the intervention, 41% persisted on PrEP at 1 month and 25% through 4 months, compared to 46% and 19%, respectively, in SOC (aRR intervention = 1.39; 95% CI = 0.93−2.09; p = 0.08). In participants treated for STIs or syndromically, 77% initiated PrEP versus 60% untreated/diagnosed (aRR = 1.14; 95% CI = 1.02−1.27); 19% versus 14% persisted on PrEP at 4 months (aRR STI/syndrome treated = 1.41; 95% CI = 0.79−2.51). Overall, 30% of 64 DBS had any TFV‐DP levels present with no difference by study arm (RR = 0.74; 95% CI: 0.38−1.41).

Conclusions

POC STI testing did not increase PrEP initiation or 1‐month persistence but showed a moderate association with 4‐month persistence. STI treatment (syndromic or confirmed) was linked to higher PrEP uptake and persistence. Integrating STI management may improve PrEP persistence among youth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisSexually Transmitted DiseasesPoint-of-Care TestingHIV InfectionsHumansFemaleMaleAdultYoung AdultAdolescentSouth AfricaPoint-of-Care SystemsAnti-HIV Agents

Stichwörter der Autor:innen

AfricaHIV preventionpre‐exposure prophylaxissexually transmitted infections

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Desmond Tutu HIV Centre, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Department of Epidemiology and Public Health, School of Public Health, University of Cape Town, Cape Town, South Africa.
  • Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Dvora Joseph Davey, Lauren Fynn, Elzette Rousseau, Linda-Gail Bekker

Förderung

  • The Bill and Melinda Gates Foundation to Desmond Tutu HIV Foundation

Zitieren

APA

Joseph Davey, D., Fynn, L., Rousseau, E., Macdonald, P., Leonard, B., Lebelo, K., Kolisa, A., Little, F., & Bekker, L. G. (2025). Evaluation of point‐of‐care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26488

Vancouver

Joseph Davey D, Fynn L, Rousseau E, Macdonald P, Leonard B, Lebelo K, et al. Evaluation of point‐of‐care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.26488

BibTeX
@article{JosephDavey2025,
  author = {Joseph Davey, Dvora and Fynn, Lauren and Rousseau, Elzette and Macdonald, Pippa and Leonard, Bryan and Lebelo, Keitumese and Kolisa, Ande and Little, Francesca and Bekker, Linda-Gail},
  title = {Evaluation of point‐of‐care diagnostics for sexually transmitted infection on oral PrEP initiation and persistence among young people in South Africa: a randomized controlled study},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  doi = {10.1002/jia2.26488}
}
Kostenlos starten →